Margaret McDaniel, PhD

Abacus Bioscience
Seattle, Washington, United States

Principal scientist at Abacus Bioscience researching cancer and autoimmune therapies. Previous research experience in type 2 immune responses and infectious disease. PhD in Immunology from UTSW.

Presentation(s):

• 0262: Preclinical Characterization of ABB071 – a Humanized anti-CD180 Antibody that Modulates Multiple Pro-inflammatory Immune Pathways for the Treatment of Autoimmune and Inflammatory Disorders

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose